ESLA Earnings

Quarterly EPS
$-0.09
Q3 2024
$0.09
Q4 2024
$-0.06
Q1 2025
$-0.15
Q2 2025
$-0.13
Q3 2025
$-0.02
Q4 2025
$-0.05
Q1 2026
$-0.05
Q2 2026
Latest RevenueN/A
Latest Net Income-2306339
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.050-2306339+66.7%
Q1 2026-$0.050-2292064+16.7%
Q4 2025-$0.020-613174-122.2%
Q3 2025-$0.130-4801149-44.4%
Q2 2025-$0.150-5544878-36.4%
Q1 2025-$0.060-2104311-500.0%
Q4 2024$0.0903.4M
Q3 2024-$0.090-3376737
Q2 2024-$0.110-3951072
Q1 2024-$0.010-469530
Estrella Immunopharma (ESLA) — Earnings